Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
Clinical trial NCT03693547 · COMPLETED
Trial details
- NCT number
- NCT03693547
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2021-06-25
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.